Kv1.5 potassium channel blockers (Cardiome)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameKv1.5 potassium channel blockers (Cardiome)
Drug Alias NameRSD-1327RSD-1379RSD-1355RSD-1384RSD-1167
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.5 blockers
TargetsVoltage-gated potassium channel subunit Kv1.5
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCorrevio Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCorrevio Pharma Corp
Active IndicationsN/A
Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A